IndraLab

Statements

BAP1 activates CDKN. 1 / 1

| 1

reach

"Within the melanoma dominant syndromes caused by cyclin dependent kinase inhibitor 2A (CDKN2A), and BRCA1 associated protein 1 (BAP1), pathogenic mutations in these genes cause increased incidence of other cancer types (e.g., pancreatic cancer, neurological tumors, renal cell carcinoma, mesothelioma) but with lower penetrance than melanoma [XREF_BIBR]."

28283772

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

BAP1 activates CDKN. 1 / 1

INDRA sources:

Databases

Reading